Bilix Co., Ltd.
- Home
- Companies
- Bilix Co., Ltd.
- News
- Investment attraction IR Bilirubin nano ...
Investment attraction IR Bilirubin nano platform technology-based treatment Bilix
Sep. 3, 2020
Courtesy ofBilix Co., Ltd.
This is the IR video of Vilix Co., Ltd., the 4th KBIC Star Day of the Health Industry Innovation and Startup Center. Introducing the treatment based on bilirubin nano-platform technology.
“Bilix Co., Ltd.” succeeded in chemical synthesis of bilirubin for the first time in the world- The nanoparticle itself: BRIXELLE-INFLA anti-inflammatory drug
- Nanoparticles + Hydrophobic Drugs: BRIXELLE-ONCO Anticancer Drug Delivery System
- Nanoparticles + SPION: BRIXELLE-SHINE Cancer Tumor Contrast Agent